Dr Alanna Thomas

Dr Alanna Thomas is a Principal Scientist with experience ranging from biomarker discovery for fluid-based biomarkers in neurodegenerative disorders to immunogenicity risk assessment in drug development. With a background in both academic research and CROs, she helps make cutting-edge platforms and techniques more accessible, empowering teams to accelerate R&D. Passionate about creating the best biomarkers for early diagnosis while ensuring patient safety and efficacy, Dr Thomas works with partners to translate complex science into meaningful breakthroughs.